ScholarIQanswers from OpenAlex

Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer

PaperCitations, authors & open-access status

Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer have?

ScholarIQcitation count

Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer has 40 citations in the OpenAlex counts ScholarIQ stores.

When was Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer published?

ScholarIQyear

Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer has 2020 year in the ScholarIQ index.

What is the open-access status of Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer?

ScholarIQoa status

Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer has gold oa status in the ScholarIQ index.

What is the DOI of Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer?

ScholarIQdoi

The DOI for Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer is on the source record.

What is the PMID of Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer?

ScholarIQpmid

The PMID for Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer is on the source record.

What is the OpenAlex record for Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer?

ScholarIQopenalex

The OpenAlex for Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial